Literature DB >> 12237212

Micromolar lidocaine selectively blocks propagating ectopic impulses at a distance from their site of origin.

Navindra Persaud1, Gary R Strichartz.   

Abstract

Abnormal impulses caused by very slowly inactivating Na channels of peripheral nerve have been proposed to play a critical role in neuropathic pain. Low concentrations of local anesthetics, often effective in treating experimental and clinical neuropathic pain, are also known to potently suppress the long after-depolarizations induced by these persistently open Na channels. However, these drug actions on impulses that have propagated away from such sites are undetermined. In the present study, the focal application of anemone toxin II (ATX, 300 nM), which slows Na-channel inactivation, produced prolonged depolarizing after-potentials and, coincidentally, induced spontaneous bursting impulse activity that propagated away from the site of ATX application in the frog sciatic nerve in vitro. The application of low concentrations of lidocaine (1-10 microM), both at the site of ATX exposure and at a distant site, selectively and reversibly inhibited the spontaneous bursting, while having no effect on the electrically stimulated initial spike of the compound action potential. Inhibition occurred as a shortening of burst episodes rather than a reduction in frequency of impulses within a burst or a reduction of intraburst impulse amplitude. Tetrodotoxin also inhibited the induced spontaneous activity, but only at concentrations that also depressed the compound action potential spike. These findings show that low concentrations of lidocaine can restore normal firing patterns in nerve where hyperexcitability has been caused by delayed Na-channel inactivation, without acting directly at the site where ectopic impulses are generated. Thus, it appears that the pattern of abnormal activity rather than an abnormally gating Na channel per se can be a target for lidocaine's therapeutic action. Copyright 2002 International Association for the Study of Pain

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237212     DOI: 10.1016/s0304-3959(02)00163-x

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  10 in total

1.  Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.

Authors:  P Y Geha; M N Baliki; D R Chialvo; R N Harden; J A Paice; A V Apkarian
Journal:  Pain       Date:  2006-10-25       Impact factor: 6.961

2.  Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience.

Authors:  Escarlata López Ramírez
Journal:  Support Care Cancer       Date:  2012-12-15       Impact factor: 3.603

3.  Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.

Authors:  Julia Ann Fleming; Bradley David O'Connor
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

Review 4.  Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs.

Authors:  Antje Barreveld; Jürgen Witte; Harkirat Chahal; Marcel E Durieux; Gary Strichartz
Journal:  Anesth Analg       Date:  2013-02-13       Impact factor: 5.108

5.  Effectiveness of Topical Lidocaine-Prilocaine Cream for Pain Control During Femoral Artery Catheterization in Adult Patients: A Prospective Study.

Authors:  Adnan I Qureshi; Muhammad A Saleem; Nishath Naseem; Emrah Aytac; Cetin Kursad Akpinar; Shawn S Wallery
Journal:  J Vasc Interv Neurol       Date:  2018-06

6.  Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician.

Authors:  Guy Hans; Dominique Robert; Johanna Verhulst; Marcel Vercauteren
Journal:  Clin Pharmacol       Date:  2010-03-30

7.  The Qualitative Hyperalgesia Profile: A New Metric to Assess Chronic Post-Thoracotomy Pain.

Authors:  Jeffrey Chi-Fei Wang; Ching-Hsia Hung; Peter Gerner; Ru-Rong Ji; Gary R Strichartz
Journal:  Open Pain J       Date:  2013

Review 8.  The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use.

Authors:  Ralf Baron; Massimo Allegri; Gerardo Correa-Illanes; Guy Hans; Michael Serpell; Gerard Mick; Victor Mayoral
Journal:  Pain Ther       Date:  2016-11-07

9.  A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis.

Authors:  Marwan N Baliki; Paul Y Geha; Rami Jabakhanji; Norm Harden; Thomas J Schnitzer; A Vania Apkarian
Journal:  Mol Pain       Date:  2008-10-25       Impact factor: 3.395

10.  The Effect and Safety of Steroid Injection in Lumbar Spinal Stenosis: With or Without Local Anesthetics.

Authors:  Sung Hyuk Song; Gi Hyeong Ryu; Jin Woo Park; Ho Jun Lee; Ki Yeun Nam; Hyojun Kim; Seung Yeon Kim; Bum Sun Kwon
Journal:  Ann Rehabil Med       Date:  2016-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.